Related Experiment Video

Updated: Aug 19, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Gemcitabine and platinum combinations in pancreatic cancer

Philip Agop Philip1

  • 1Division of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA. philipp@karmanos.org

Cancer
|September 5, 2002
PubMed

Insights

Gemcitabine and cisplatin combination therapy shows promise for pancreatic cancer treatment, improving response rates and survival. Further large-scale studies are needed to confirm these findings.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Pancreatic cancer treatment has seen limited progress over decades.
  • Gemcitabine is a promising agent, particularly in combination therapies.

Purpose of the Study:

  • To evaluate the efficacy and toxicity of gemcitabine-cisplatin combination therapy for pancreatic cancer.

Main Methods:

  • Review of pilot Phase II studies combining gemcitabine with cisplatin.
  • Analysis of reported objective response rates, survival outcomes, and toxicities.

Main Results:

  • The gemcitabine-cisplatin combination demonstrated improved objective response rates and survival in pilot studies.
  • The primary toxicity observed was myelosuppression, which was more pronounced than with single-agent gemcitabine.
  • Neutropenic fever and spontaneous bleeding were infrequent side effects.

Conclusions:

  • Gemcitabine-cisplatin combination therapy shows potential for enhancing pancreatic cancer treatment outcomes.
  • Larger, randomized studies are essential to validate the efficacy and safety findings from pilot trials.

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...